We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 58

U.S. Trade Rep launches WTO action against India
  • Shook Hardy & Bacon LLP
  • India, USA
  • February 13 2014

U.S. Trade Representative Michael Froman has announced that the United States has requested dispute settlement consultations with India before the


Indian Parliament considers bill to regulate drugs and cosmetics
  • Shook Hardy & Bacon LLP
  • India
  • September 12 2013

Officials in India have introduced a bill that would establish a Central Drugs Authority (CDA) headed by the secretary of health and family


India’s Supreme Court orders checks on carbonated soft drinks
  • Shook Hardy & Bacon LLP
  • India
  • October 25 2013

India's India’s Supreme Court has reportedly accepted a government scientific panel’s finding that the chemical additives in soft drinks e.g


Drug makers complain about slow regulatory approvals in India
  • Shook Hardy & Bacon LLP
  • Global, India
  • February 21 2013

Pharmaceutical companies have reportedly begun shifting their clinical trials out of India, claiming that bureaucrats have been slow to approve them


India to consider ban on importing animal-tested cosmetics
  • Shook Hardy & Bacon LLP
  • India, USA
  • January 9 2014

Following the June 2013 decision to prohibit the testing of domestically produced cosmetics and their ingredients on animals (details about which


India’s guidance for biosimilar drugs draws cautious industry welcome
  • Shook Hardy & Bacon LLP
  • India
  • September 20 2012

According to a news source, industry has given India’s new guidelines for biosimilar drugs, launched August 15, 2012, a “cautious welcome.”


Indian drug industry disputes prohibition on brand names
  • Shook Hardy & Bacon LLP
  • India
  • November 1 2012

According to a news source, the Indian Drugs Manufacturing Association is gearing up to challenge action taken by the country’s drug controller to prevent the sale of medicines under brand names as part of an effort to accelerate sales of less-expensive generics


Scientists oppose SCI’s recommended moratorium on biotech crops
  • Shook Hardy & Bacon LLP
  • India
  • November 1 2012

After an expert committee appointed by the Supreme Court of India (SCI) recommended halting field trials of transgenic food crops for 10 years, biotechnologists, agricultural scientists and agribiotech-industry heads reportedly gathered in Bangalore to oppose the recommendations


India bans animal testing for cosmetics
  • Shook Hardy & Bacon LLP
  • India
  • July 12 2013

The Bureau of Indian Standards (BIS) has reportedly announced that it will implement a ban on animal testing for cosmetics, making it the first South


Toxic chemicals allegedly found in beauty products in India
  • Shook Hardy & Bacon LLP
  • USA, India
  • February 7 2014

A study conducted by the Pollution Monitoring Lab (PML) at India's Centre for Science and Environment (CSE), has reportedly found excessive levels of